RHÖN-KLINIKUM Aktiengesellschaft (RHK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, RHÖN-KLINIKUM Aktiengesellschaft (RHK) has a cash flow conversion efficiency ratio of -0.019x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-25.60 Million ≈ $-29.93 Million USD) by net assets (€1.33 Billion ≈ $1.55 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
RHÖN-KLINIKUM Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how RHÖN-KLINIKUM Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of RHÖN-KLINIKUM Aktiengesellschaft for a breakdown of total debt and financial obligations.
RHÖN-KLINIKUM Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RHÖN-KLINIKUM Aktiengesellschaft ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sirio Pharma
SHE:300791
|
0.038x |
|
Cybrid Technologies Inc
SHG:603212
|
0.039x |
|
UNITIL Corporation
NYSE:UTL
|
0.026x |
|
MilDef Group AB
ST:MILDEF
|
0.048x |
|
Indian Metals & Ferro Alloys Limited
NSE:IMFA
|
0.131x |
|
Anhui Huilong Agricultural Means of Production Co Ltd
SHE:002556
|
0.153x |
|
Cowealth Medical China Co.Ltd.
SHG:603122
|
N/A |
|
Zhejiang Zomax Transmission
SHG:603767
|
0.010x |
Annual Cash Flow Conversion Efficiency for RHÖN-KLINIKUM Aktiengesellschaft (2002–2024)
The table below shows the annual cash flow conversion efficiency of RHÖN-KLINIKUM Aktiengesellschaft from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see RHK stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €1.33 Billion ≈ $1.55 Billion |
€127.60 Million ≈ $149.18 Million |
0.096x | +13.03% |
| 2023-12-31 | €1.28 Billion ≈ $1.50 Billion |
€109.00 Million ≈ $127.43 Million |
0.085x | +76.70% |
| 2022-12-31 | €1.25 Billion ≈ $1.46 Billion |
€60.30 Million ≈ $70.50 Million |
0.048x | -39.47% |
| 2021-12-31 | €1.22 Billion ≈ $1.43 Billion |
€97.50 Million ≈ $113.99 Million |
0.080x | -16.37% |
| 2020-12-31 | €1.19 Billion ≈ $1.39 Billion |
€113.30 Million ≈ $132.46 Million |
0.095x | +138.65% |
| 2019-12-31 | €1.19 Billion ≈ $1.39 Billion |
€47.30 Million ≈ $55.30 Million |
0.040x | -6.59% |
| 2018-12-31 | €1.16 Billion ≈ $1.36 Billion |
€49.50 Million ≈ $57.87 Million |
0.043x | -40.16% |
| 2017-12-31 | €1.13 Billion ≈ $1.32 Billion |
€80.30 Million ≈ $93.88 Million |
0.071x | -27.17% |
| 2016-12-31 | €1.11 Billion ≈ $1.30 Billion |
€109.10 Million ≈ $127.55 Million |
0.098x | +54.76% |
| 2015-12-31 | €1.11 Billion ≈ $1.30 Billion |
€70.20 Million ≈ $82.07 Million |
0.063x | +60.73% |
| 2014-12-31 | €1.25 Billion ≈ $1.46 Billion |
€49.20 Million ≈ $57.52 Million |
0.039x | -68.79% |
| 2013-12-31 | €1.67 Billion ≈ $1.95 Billion |
€210.40 Million ≈ $245.98 Million |
0.126x | +45.88% |
| 2012-12-31 | €1.61 Billion ≈ $1.88 Billion |
€139.10 Million ≈ $162.62 Million |
0.087x | -41.43% |
| 2011-12-31 | €1.60 Billion ≈ $1.87 Billion |
€236.20 Million ≈ $276.14 Million |
0.148x | -0.26% |
| 2010-12-31 | €1.50 Billion ≈ $1.75 Billion |
€221.50 Million ≈ $258.96 Million |
0.148x | -0.80% |
| 2009-12-31 | €1.42 Billion ≈ $1.66 Billion |
€212.50 Million ≈ $248.43 Million |
0.149x | -28.98% |
| 2008-12-31 | €889.26 Million ≈ $1.04 Billion |
€187.00 Million ≈ $218.62 Million |
0.210x | -11.07% |
| 2007-12-31 | €769.71 Million ≈ $899.87 Million |
€182.00 Million ≈ $212.78 Million |
0.236x | -30.64% |
| 2006-12-31 | €691.10 Million ≈ $807.97 Million |
€235.60 Million ≈ $275.44 Million |
0.341x | +11.42% |
| 2005-12-31 | €609.22 Million ≈ $712.24 Million |
€186.40 Million ≈ $217.92 Million |
0.306x | -0.04% |
| 2004-12-31 | €545.92 Million ≈ $638.24 Million |
€167.10 Million ≈ $195.36 Million |
0.306x | +35.62% |
| 2003-12-31 | €508.19 Million ≈ $594.13 Million |
€114.70 Million ≈ $134.10 Million |
0.226x | -5.63% |
| 2002-12-31 | €459.94 Million ≈ $537.72 Million |
€110.00 Million ≈ $128.60 Million |
0.239x | -- |
About RHÖN-KLINIKUM Aktiengesellschaft
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company also operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.